Recombinant Human IL-7-HYFC

Recombinant Human IL-7-HYFC Uses, Dosage, Side Effects, Food Interaction and all others data.

Recombinant Human IL-7-HYFC (also known as NT-I7) is a long-acting human interleukin-7 (IL-7) fusion protein that promotes T-cell development, contributing to the immune response. Compared to endogenous IL-7, NT-I7 is more stable and potent, has a longer half-life, and has better bioavailability. This drug is currently being investigated in the areas of oncology, immunology, and infectious disease.

Trade Name Recombinant Human IL-7-HYFC
Generic Efineptakin alfa
Efineptakin alfa Other Names Efineptakin alfa, Hyleukin, NT-I7, Recombinant human IL-7-HYFC
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Recombinant Human IL-7-HYFC
Recombinant Human IL-7-HYFC

Innovators Monograph

You find simplified version here Recombinant Human IL-7-HYFC


*** Taking medicines without doctor's advice can cause long-term problems.
Share